About 2 results found for searched term "Tixagevimab" (0.157 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25149 | Tixagevimab | Anti-infection |
| AZD8895 | ||
| Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor. | ||
| M25148 | Cilgavimab | Anti-infection |
| AZD-1061; COV2-2130 | ||
| Cilgavimab (AZD-1061; COV2-2130) is a humanized SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab . Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
